Search Keyword:


Search option:


IID00126
UniprotP24928
ProteinDNA-directed RNA polymerase II subunit RPB1
GenePOLR2A
OrganismHomo sapiens
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
1970
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seqdisorder 1593-1960
 Evidence CD¸ NMR Reference
       Region 1593-1960 disorder
Seq 1713-1740 Hetero tetramer : Q5V8Z9
 Evidence X-RAY 5m3j X Reference
       Region 5m3j X 1713-1718 disorder
       Region 5m3j X 1719-1727 order
       Region 5m3j X 1728-1740 disorder
Seq 1713-1740 Hetero tetramer : H6QM92
 Evidence X-RAY 5m3h Y Reference
       Region 5m3h Y 1713-1717 disorder
       Region 5m3h Y 1718-1727 order
       Region 5m3h Y 1728-1740 disorder
 Evidence X-RAY 5m3h X Reference
       Region 5m3h X 1713-1718 order
       Region 5m3h X 1719-1740 disorder
Seq 1787-1805 Hetero dimer : Q96P16
 Evidence X-RAY 4jxt B Reference
       Region 4jxt B 1787-1787 disorder
       Region 4jxt B 1788-1798 order
       Region 4jxt B 1799-1805 disorder
Seq 1790-1803 Hetero dimer : IID00590Complex
 Evidence X-RAY 3d9p Y Reference
       Region 3d9p Y 1790-1792 order
       Region 3d9p Y 1793-1803 disorder
 Evidence X-RAY 3d9p Z Reference
       Region 3d9p Z 1790-1794 disorder
       Region 3d9p Z 1795-1802 order
       Region 3d9p Z 1803-1803 disorder
 Evidence X-RAY 3d9n Z Reference
       Region 3d9n Z 1790-1794 disorder
       Region 3d9n Z 1795-1803 order
 Evidence X-RAY 3d9n Y Reference
       Region 3d9n Y 1790-1794 disorder
       Region 3d9n Y 1795-1803 order
 Evidence X-RAY 3d9m Y Reference
       Region 3d9m Y 1790-1792 order
       Region 3d9m Y 1793-1803 disorder
 Evidence X-RAY 3d9m Z Reference
       Region 3d9m Z 1790-1794 disorder
       Region 3d9m Z 1795-1803 order
 Evidence X-RAY 3d9l Z Reference
       Region 3d9l Z 1790-1794 disorder
       Region 3d9l Z 1795-1802 order
       Region 3d9l Z 1803-1803 disorder
 Evidence X-RAY 3d9l Y Reference
       Region 3d9l Y 1790-1799 order
       Region 3d9l Y 1800-1803 disorder
 Evidence X-RAY 3d9k Y Reference
       Region 3d9k Y 1790-1794 disorder
       Region 3d9k Y 1795-1801 order
       Region 3d9k Y 1802-1803 disorder
 Evidence X-RAY 3d9k Z Reference
       Region 3d9k Z 1790-1798 order
       Region 3d9k Z 1799-1803 disorder
Seq 1790-1803 Hetero trimer : IID00590Complex
 Evidence X-RAY 3d9o Z Reference
       Region 3d9o Z 1790-1794 disorder
       Region 3d9o Z 1795-1803 order
Seq 1795-1803 Hetero dimer : IID00394Complex
 Evidence X-RAY 2ght D Reference
       Region 2ght D 1796-1803 order
 Evidence X-RAY 2ght C Reference
       Region 2ght C 1796-1797 disorder
       Region 2ght C 1798-1802 order
       Region 2ght C 1803-1803 disorder
 Evidence X-RAY 2ghq D Reference
       Region 2ghq D 1795-1803 order
 Evidence X-RAY 2ghq C Reference
       Region 2ghq C 1795-1797 disorder
       Region 2ghq C 1798-1802 order
       Region 2ghq C 1803-1803 disorder
Seq 1804-1816 Hetero dimer : IID00499Complex
 Evidence NMR 2lto B Reference
       Region 2lto B 1804-1816 order
SeqProS verified 1713-1727 Hetero tetramer : H6QM92
       Region 5m3h X 1713-1718 order
       Region 5m3h Y 1718-1727 order
       Region 1593-1960 disorder
SeqProS verified 1719-1727 Hetero tetramer : Q5V8Z9
       Region 5m3j X 1719-1727 order
       Region 1593-1960 disorder
SeqProS verified 1788-1803 Hetero trimer : IID00590Complex
       Region 3d9o Z 1795-1803 order
       Region 1593-1960 disorder
SeqProS verified 1788-1803 Hetero dimer : Q96P16
       Region 4jxt B 1788-1798 order
       Region 1593-1960 disorder
SeqProS verified 1788-1803 Hetero dimer : IID00590Complex
       Region 3d9n Y 1795-1803 order
       Region 3d9n Z 1795-1803 order
       Region 3d9k Y 1795-1801 order
       Region 3d9k Z 1790-1798 order
       Region 3d9p Y 1790-1792 order
       Region 3d9p Z 1795-1802 order
       Region 3d9l Y 1790-1799 order
       Region 3d9l Z 1795-1802 order
       Region 3d9m Y 1790-1792 order
       Region 3d9m Z 1795-1803 order
       Region 1593-1960 disorder
SeqProS verified 1795-1803 Hetero dimer : IID00394Complex
       Region 2ghq C 1798-1802 order
       Region 2ghq D 1795-1803 order
       Region 2ght C 1798-1802 order
       Region 2ght D 1796-1803 order
       Region 1593-1960 disorder
SeqProS verified 1804-1816 Hetero dimer : IID00499Complex
       Region 2lto B 1804-1816 order
       Region 1593-1960 disorder
Seqphosphorylation
    1933-1933 Phosphothreonine
    1934-1934 Phosphoserine
    1930-1930 Phosphotyrosine
    1931-1931 Phosphoserine
    1929-1929 Phosphothreonine
    1926-1926 Phosphothreonine
    1927-1927 Phosphoserine
    1923-1923 Phosphotyrosine
    1920-1920 Phosphoserine
    1919-1919 Phosphothreonine
    1917-1917 Phosphoserine
    1916-1916 Phosphotyrosine
    1915-1915 Phosphothreonine
    1913-1913 Phosphoserine
    1912-1912 Phosphothreonine
    1909-1909 Phosphotyrosine
    1906-1906 Phosphoserine
    1899-1899 Phosphoserine
    1896-1896 Phosphoserine
    1894-1894 Phosphothreonine
    1885-1885 Phosphothreonine
    1874-1874 Phosphotyrosine
    1875-1875 Phosphoserine
    1877-1877 Phosphothreonine
    1878-1878 Phosphoserine
    1881-1881 Phosphotyrosine
    1882-1882 Phosphoserine
    1870-1870 Phosphothreonine
    1868-1868 Phosphoserine
    1867-1867 Phosphotyrosine
    1864-1864 Phosphoserine
    1861-1861 Phosphoserine
    1863-1863 Phosphothreonine
    1860-1860 Phosphotyrosine
    1857-1857 Phosphoserine
    1854-1854 Phosphothreonine
    1850-1850 Phosphoserine
    1849-1849 Phosphoserine
    1847-1847 Phosphoserine
    1845-1845 Phosphoserine
    1843-1843 Phosphoserine
    1840-1840 Phosphothreonine
    217-217 Phosphoserine
    27-27 Phosphoserine
Seqacetylation
    1936-1936 N6-acetyllysine; alternate
    1922-1922 N6-acetyllysine; alternate
    1887-1887 N6-acetyllysine; alternate
    1866-1866 N6-acetyllysine; alternate
    1-1 N-acetylmethionine
 
Prediction
NeProc
Disorder 1-10,162-178,333-348,1267-1277,1487-1970
Order 11-161,179-267,274-332,349-1266,1279-1486
ProS 5-10,162-178,333-348,1502-1523,1528-1562,1585-1590,1621-1633,1654-1658,1687-1692,1697-1706,1718-1723,1746-1749,1767-1784,1796-1800,1809-1818,1851-1858,1872-1877,1884-1888,1913-1921,1938-1970
AlphaFold
Disorder 1-11,156-182,267-269,432-433,729-731,1103-1117,1199-1203,1264-1280,1389-1389,1487-1525,1538-1538,1541-1970
Order 12-155,183-266,270-431,434-728,732-1102,1118-1198,1204-1263,1281-1388,1390-1486,1526-1537,1539-1540
Pfam Hmmer
PF04997 15-354 1.8e-164
PF00623 356-521 1.7e-111
PF04983 524-692 8.6e-80
PF05000 717-823 3e-55
PF04998 830-1428 8.3e-150
SEG 951-964 ,1271-1283 ,1541-1560 ,1562-1587 ,1608-1959
Function
Function in SwissProt
DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Largest and catalytic component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Forms the polymerase active center together with the second largest subunit. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB1 is part of the core element with the central large cleft, the clamp element that moves to open and close the cleft and the jaws that are thought to grab the incoming DNA template. At the start of transcription, a single-stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol II. A bridging helix emanates from RPB1 and crosses the cleft near the catalytic site and is thought to promote translocation of Pol II by acting as a ratchet that moves the RNA-DNA hybrid through the active site by switching from straight to bent conformations at each step of nucleotide addition. During transcription elongation, Pol II moves on the template as the transcript elongates. Elongation is influenced by the phosphorylation status of the C-terminal domain (CTD) of Pol II largest subunit (RPB1), which serves as a platform for assembly of factors that regulate transcription initiation, elongation, termination and mRNA processing. Regulation of gene expression levels depends on the balance between methylation and acetylation levels of tha CTD-lysines (By similarity). Initiation or early elongation steps of transcription of growth-factors-induced immediate early genes are regulated by the acetylation status of the CTD (PubMed:24207025). Methylation and dimethylation have a repressive effect on target genes expression (By similarity).
(Microbial infection) Acts as an RNA-dependent RNA polymerase when associated with small delta antigen of Hepatitis delta virus, acting both as a replicate and transcriptase for the viral RNA circular genome.